RESUMO
BACKGROUND: The treatment of diabetes with plant ingredients such as in Traditional Chinese Medicine (TCM) is an alternative to classical chemotherapy. OBJECTIVE: This study aims to explore the hypoglycemic effect of Trichosanthes pericarpium powder (TP) and intestinal bacteria transplantation in type 2 diabetic mice. The relationship between intestinal bacteria transplantation and improvement in insulin resistance was also investigated. METHODS: The polyphenols and terpenoids in the TP were identified by LC-MS/MS. Streptozotocin was used to induce a mouse model of type 2 diabetes. Diabetic mice were treated with different doses of TP and the intestinal bacteria obtained from the high-dose TP group for four weeks. RESULTS: As a result, FBG levels were found to be significantly reduced in diabetic mice, weight gain and organ enlargement were alleviated, and insulin resistance was significantly improved. TP administration also improved the disorder in intestinal bacteria in diabetic mice. Besides, TP can increase the liver AMPK, SIRT1, GLUT1, and GLUT4 gene expression, while down-regulated PEPCK and G6Pase gene expression suggest a potential mechanism for hypoglycemia in diabetic mice. CONCLUSION: Oral administration of Trichosanthes pericarpium powder in the treatment of diabetes may be achieved by restoring hepatic function, improving insulin resistance, and the dynamic balance of intestinal bacteria.
Assuntos
Diabetes Mellitus Experimental , Diabetes Mellitus Tipo 2 , Resistência à Insulina , Trichosanthes , Camundongos , Animais , Hipoglicemiantes/farmacologia , Hipoglicemiantes/uso terapêutico , Diabetes Mellitus Tipo 2/tratamento farmacológico , Trichosanthes/metabolismo , Diabetes Mellitus Experimental/tratamento farmacológico , Cromatografia Líquida , Pós/metabolismo , Pós/farmacologia , Pós/uso terapêutico , Glicemia/metabolismo , Espectrometria de Massas em Tandem , Bactérias/metabolismo , Insulina/metabolismo , FígadoRESUMO
BACKGROUND: A mouse model in which diabetes mellitus was induced by low-dose streptozotocin (STZ) injection combined with a high-fat diet was used to study the effect of two water cress (Lepidium savitum) preparations. Diabetic mice were treated with dried cress powder or with water-soluble extracts (tested at two doses), together with proper control groups. The mice were evaluated after 4 weeks of continuous intervention for type 2 diabetic and associated markers. We determined blood glucose, body weight, total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL), high-density lipoprotein (HDL), serum insulin levels, and DNA integrity of hepatic cells. The concentrations of malondialdehyde (MDA) and lipid peroxide (LPO) and the activities of four enzymes that are part of the antioxidant defense system were determined in liver samples, as well as gene expression (by semi-quantitative reverse transcription polymerase chain reaction) and enzyme activity of IRS-1, IRS-2, PI3K, AKT-2, and GLUT4. RESULTS: After 4 weeks of intervention, the levels of TC, TG, and LDL cholesterol were significantly (P < 0.5) decreased and HDL cholesterol was significantly increased. Enzyme activities of liver superoxide dismutase, glutathione, glutathione peroxidase, and catalase were significantly increased, whereas MDA and LPO concentrations were significantly reduced. The transcription level of the five genes assessed was increased, with corresponding increases in protein expression. CONCLUSION: Oral uptake of garden cress can significantly reduce the blood glucose and improve the blood lipid metabolism of diabetic mice. Considerable improvements in the activity of antioxidant defense enzymes were observed in type 2 diabetic mice that improved the body's antioxidant emergency response. © 2019 Society of Chemical Industry.
Assuntos
Glicemia/metabolismo , Dieta Hiperlipídica , Lepidium sativum/química , Lipídeos/sangue , Animais , Antioxidantes/metabolismo , Catalase/metabolismo , HDL-Colesterol/sangue , LDL-Colesterol/sangue , Fragmentação do DNA , Diabetes Mellitus Experimental/prevenção & controle , Regulação da Expressão Gênica , Transportador de Glucose Tipo 4/genética , Transportador de Glucose Tipo 4/metabolismo , Glutationa/metabolismo , Glutationa Peroxidase/metabolismo , Hemoglobinas Glicadas/metabolismo , Hipoglicemiantes/farmacologia , Insulina/sangue , Proteínas Substratos do Receptor de Insulina/genética , Proteínas Substratos do Receptor de Insulina/metabolismo , Peróxidos Lipídicos/metabolismo , Masculino , Malondialdeído/metabolismo , Camundongos , Camundongos Endogâmicos ICR , Estresse Oxidativo/efeitos dos fármacos , Fosfatidilinositol 3-Quinases/genética , Fosfatidilinositol 3-Quinases/metabolismo , Extratos Vegetais/farmacologia , Superóxido Dismutase/metabolismo , Triglicerídeos/sangueRESUMO
BACKGROUND: Enteric dysbiosis is associated with chronic inflammation and interacts with obesity and insulin resistance. Obesity and diabetes are induced in ICR (Institute of Cancer Research) mice fed a high-fat diet and administered a streptozocin injection. These mice were treated with normal rice (NR), normal rice with a high resistant starch content (NRRS) or Se-rich rice (selenium-enriched rice) with a high resistant starch content (SRRS). RESULTS: Faecal cell counts of Bifidobacterium, Lactobacillus and Enterococcus were significantly higher in SRRS-treated mice than in diabetic controls, while Enterobacter cloacae were lower. Similar results were also found in NRRS-treated mice. In contrast, no significant difference was found between NR-treated and diabetic control groups. The treatments with SRRS and NRRS reduced the faecal pH values of the diabetic mice. Regarding the inflammatory factor levels, lower levels of serum C-reactive protein (CRP), tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6), nuclear factor-k-gene binding (NF-κB) and leptin (LEP) and higher adiponutrin (ADPN) levels were found in the SRRS and NRRS-treated mice compared with the diabetic and NR-treated mice. In addition, the CRP, IL-6 and NF-κB levels in the SRRS-treated mice were significantly reduced compared with those observed in the NRRS-treated mice. The reverse transcription-PCR (RT-PCR) results showed that the SRRS and NRRS-treated mice presented higher expression levels of orphan G protein-coupled receptor 41 (GPR41) and orphan G protein-coupled receptor 43 (GPR43) proteins compared with diabetic mice and NR-treated mice. CONCLUSION: These results indicate that treatments with rice high in RS exert beneficial effects by improving enteric dysbiosis and chronic inflammation. In addition, selenium and RS may exert synergistic effects on chronic inflammation. © 2016 Society of Chemical Industry.
Assuntos
Diabetes Mellitus/dietoterapia , Disbiose/dietoterapia , Farinha/análise , Oryza/química , Extratos Vegetais/administração & dosagem , Selênio/administração & dosagem , Amido/metabolismo , Animais , Diabetes Mellitus/genética , Diabetes Mellitus/imunologia , Diabetes Mellitus/metabolismo , Disbiose/genética , Disbiose/imunologia , Disbiose/metabolismo , Humanos , Interleucina-6/genética , Interleucina-6/imunologia , Masculino , Proteínas de Membrana/genética , Proteínas de Membrana/imunologia , Camundongos , Camundongos Endogâmicos ICR , NF-kappa B/genética , NF-kappa B/imunologia , Obesidade/dietoterapia , Obesidade/genética , Obesidade/imunologia , Obesidade/metabolismo , Oryza/metabolismo , Extratos Vegetais/metabolismo , Selênio/análise , Amido/química , Fator de Necrose Tumoral alfa/genética , Fator de Necrose Tumoral alfa/imunologiaRESUMO
In this paper, we have investigated the hypoglycemic and anti-inflammatory effects of seabuckthorn seed protein (SSP) on streptozocin (STZ)-induced diabetic IRC mice. The effects of SSP on the body weight (BW), fasting blood glucose (FBG) levels, serum lipids, inflammatory factors and insulin (SIN) levels of normal and diabetic mice have been investigated. SSP has been shown to reduce insulin resistance (IR) and control the effects of C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and nuclear factor-κ-gene binding (NF-κB). In addition, this paper further validates the hypoglycemic and anti-inflammatory effects of seabuckthorn procyanidins (SPR) and seabuckthorn polysaccharides (SPO) in diabetic mice and the experimental results were consistent with previous studies. Moreover, results from animal experiments showed that SSP has a significant hypoglycemic and anti-inflammatory effect as evidenced by the lower BW, FBG levels, SIN and lipid contents of diabetic mice treated with SSP compared to the diabetic control mice.
Assuntos
Anti-Inflamatórios/administração & dosagem , Diabetes Mellitus Experimental/tratamento farmacológico , Hippophae/química , Hipoglicemiantes/administração & dosagem , Extratos Vegetais/administração & dosagem , Proteínas de Plantas/administração & dosagem , Animais , Glicemia/metabolismo , Diabetes Mellitus Experimental/genética , Diabetes Mellitus Experimental/metabolismo , Humanos , Insulina/metabolismo , Interleucina-6/genética , Interleucina-6/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos ICR , NF-kappa B/genética , NF-kappa B/metabolismo , Sementes/química , Fator de Necrose Tumoral alfa/genética , Fator de Necrose Tumoral alfa/metabolismoRESUMO
The antioxidant effects of the triterpenoid-rich extracts from Euryale ferox shell (ES) have been confirmed in vitro. This study examined whether the triterpenoid-rich extract from ES eases human hyperglycemia and diabetes caused by metabolic disorders. Normal and streptozocin (STZ)-induced diabetic mice were used as controls for the four groups that received the triterpenoid-rich extracts of ES suspended in distilled water orally at doses of 200, 300, 400, 500±2 mg/L. Body weight, blood glucose and pancreatic tissue morphology were observed after 4 weeks. The expression of protein tyrosine phosphatase-1B (PTP1B) and insulin receptor substrate (IRS-1) proteins, which are related to the regulation of glucose metabolism in vivo, were also investigated. Compared with the model group (LD50 900±2 mg/L), it was found that the triterpenoid-rich extracts of ES could regulate glucose metabolism (P<0.01) and cause body weight to return to normal levels (P<0.05). Islet morphology recovered well, the expression of the negative regulation protein PTP1B gene was reduced and insulin receptor IRS-1 protein expression was increased. These data prove that the triterpenoid-rich extracts from ES have a therapeutic effect on diabetes by insulin resistance.
Assuntos
Diabetes Mellitus Experimental/tratamento farmacológico , Hipoglicemiantes/farmacologia , Nymphaeaceae , Fitoterapia , Extratos Vegetais/farmacologia , Triterpenos/farmacologia , Animais , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Experimental/patologia , Proteínas Substratos do Receptor de Insulina/fisiologia , Masculino , Camundongos , Proteína Tirosina Fosfatase não Receptora Tipo 1/fisiologia , EstreptozocinaRESUMO
The hypoglycemic and hypolipidemic effects of a triterpenoid-rich extract from the Euryale shell (ES) was analyzed in streptozotocin-induced diabetic mice. Normal and diabetic mice treated with glimepiride were used as negative and positive controls, respectively. Body weight, organ weight index and cholesterol-related lipid profile parameters were observed after 4 weeks. The hypoglycemic activity was assessed by fasting blood glucose (FBG) and fasting insulin (FINS) to calculate the insulin sensitivity index (ISI). In addition, the potentially regulative mechanisms on insulin resistance were discussed. The results indicated that a triterpenoid-rich extract of ES could inhibit reduction in the body weight of diabetic mice and regulate glucose metabolism. The hypolipidemic action after this extract supplementation was confirmed by significant (p<0.05) decreases in the levels of cholesterol, LDL and triglycerides and increase in HDL compared with the untreated diabetic mice, especially when using a high dose, which suggested that the ES extract could effectively reverse the abnormal enlargement of the liver and spleen (p<0.01). The present data suggest that the triterpenoid-rich extract from the ES has both hypoglycemic and hypolipidemic effects that can not only help cure and manage diabetes but also improve insulin resistance (IR).